Usefulness of zinc preparation administration in zinc deficiency dialysis patients

Usefulness of zinc preparation administration in zinc deficiency dialysis patients - Usefulness of zinc preparation administration in zinc deficiency dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042511

Enrollment

100

Registered

2021-06-30

Start date

2020-10-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zinc deficiency Latent zinc deficiency

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with deficiency or latent deficiency measured for serum zinc levels

Exclusion criteria

Exclusion criteria: Patients receiving zinc preparations before the start of evaluation Patients who discontinued administration after exceeding the doctor's judgment and serum zinc concentration standard value Patients receiving more than the package insert of Polarezinc Orally Disintegrating Tablets

Design outcomes

Primary

Measure	Time frame
Serum zinc concentration ESA dose Hb Albumin leakage	—

Secondary

Measure	Time frame
age Dialysis history Dialysis conditions Dialysate TSAT Ferritin Fedin administration period Ferromia oral dose Riona oral dose Pettle dose Total zinc dose TP Correction Ca P PTH K Mg Kt/V Beta 2 microglobulin HS-CRP Cr index Serum Alb nPCR ERI Lipid	—

Countries

Japan

Contacts

Public ContactRyosuke Hatonari

Kawashima Hospital Group Faculty of Clinical Engineering

r.hatonari@khg.or.jp088-631-0110

Outcome results